Close Menu

NEW YORK – OncoCyte announced after the close of the market Friday that it has entered into an equity distribution agreement with Piper Sandler to create an at-the-market equity program under which it may sell up to an aggregate of $25 million in shares of the company’s common stock.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.